Publication | Closed Access

DSG3 is overexpressed in head neck cancer and is a potential molecular target for inhibition of oncogenesis

Oncogenic AgentMedicinePathologyHead And Neck CancerPotential Molecular TargetCell BiologyTumor SuppressorCancer GeneticsHead Neck CancerCancer BiologyGliomaCancer ResearchNeck OncologyTumor Biology